metiopropamine 对小鼠认知功能和单氨基系统的影响
Mohd Khairulanwar Bunaim1,2, Nor Syafinaz Yaakob1, Hanafi Ahmad Damanhuri3
1Faculty of Pharmacy, Centre for Drug and Herbal Development, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Drug and chemical toxicology
|June 17, 2025
概括
甲基胺 (MPA) 损害了小鼠的记忆和工作能力,类似于甲基胺. 这些影响与前额叶皮质中多巴胺和p-ERK1/2的减少有关,表明MPA的神经毒性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 新型精神活性物质 (NPS) 像甲基胺 (MPA) 需要神经毒性研究.
- 甲基胺 (MPA) 与甲基胺 (METH) 的结构相似.
研究的目的:
- 为了研究MPA对小鼠行为的神经毒性作用.
- 分析MPA对神经递质水平和大脑中的p-ERK1/2表达的影响.
主要方法:
- 小鼠每天接受内注射盐水,MPA (1或3毫克/公斤) 或METH (1毫克/公斤) 7天.
- 行为测试包括新型物体识别 (NORT),8臂辐射迷宫 (8-ARM) 和开放场测试 (OFT).
- 测量了大脑单胺神经递质水平和前额叶皮层 (PFC) 中的p-ERK1/2表达.
主要成果:
- 在NORT中,MPA (3 mg/kg) 显著损害了识别记忆,与METH (1 mg/kg) 相比.
- 在8-ARM测试中,MPA (3 mg/kg) 也降低了工作和参考记忆,并在OFT中显示出抗焦虑作用.
- 认知缺陷与降低多巴胺基因参数和PFC中的p-ERK1/2表达相关.
结论:
- 在小鼠中,MPA的摄入会导致记忆障碍.
- 由MPA诱导的神经毒性向前额叶皮层中的多巴胺传递.
- 降低多巴胺活性和p-ERK1/2水平有助于MPA的认知效应.
相关概念视频
01:29Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
214
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
214
01:25Adrenergic Agonists: Indirect-Acting Agents
1.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.9K